前列腺导管腺癌和导管内癌中GLUT1膜表达高而PSMA膜表达低
研究比较87例未治疗的前列腺导管腺癌(DAC)和/或导管内癌(IDC-P)患者与97例Gleason评分≥8的前列腺腺泡癌(PAC)患者的活检和前列腺切除标本,采用免疫组化评分检测PSMA和GLUT1表达。结果显示DAC/IDC-P中PSMA表达低于PAC,而GLUT1膜表达高于纯PAC及邻近PAC,提示DAC/IDC-P可能具有更高的葡萄糖代谢。
要点
- DAC/IDC-P中PSMA表达显著低于PAC(141.2 vs 78.6,p<0.001)。
- DAC/IDC-P中GLUT1膜表达显著高于纯PAC(13.0 vs 6.6,p=0.025)。
- DAC/IDC-P的GLUT1膜表达也显著高于邻近PAC(13.0 vs 2.0,p<0.001)。
核心结论
- DAC/IDC-P组织中PSMA表达低,而GLUT1表达尤其是GLUT1膜表达高。
- 这些发现提示DAC/IDC-P可能具有更高的葡萄糖代谢,并引发对靶向膜GLUT1作为DAC/IDC-P及其他高葡萄糖代谢前列腺癌新型抗癌策略的兴趣。
研究设计与样本
- 研究纳入2017年8月至2022年8月间87例未治疗的DAC或/和IDC-P患者以及97例Gleason评分≥8的PAC患者的前列腺活检和前列腺切除标本。
- 对患者各种癌成分样本进行免疫组化染色和评分,以反映PSMA和GLUT1的蛋白表达水平。
主要发现
- PAC中PSMA表达显著高于DAC/IDC-P(141.2 vs 78.6,p<0.001)。
- DAC/IDC-P与邻近PAC之间PSMA表达无显著差异(78.6 vs 93.4,p=0.166)。
- DAC/IDC-P中GLUT1表达高于邻近PAC(68.6 vs 51.3,p=0.007),但仍低于纯PAC(68.6 vs 93.1,p=0.0014)。
- DAC/IDC-P中GLUT1膜表达显著高于纯PAC(13.0 vs 6.6,p=0.025),也显著高于邻近DAC/IDC-P的PAC(13.0 vs 2.0,p<0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Both Ductal Adenocarcinoma (DAC) and Intraductal Carcinoma (IDC) of the prostate are generally associated with aggressive clinical behavior and poor prognosis, which were linked with discordant FDG positivity and low Prostate-Specific Membrane Antigen (PSMA) expression. A recent study only cited a DAC patient with low 68Ga-PSMA-11 PET/CT uptake but high 18F-FDG PET/CT uptake, however, there is lack of directly compared articles nor large data sets. Hence, the objective of this study was to investigate the expression of PSMA and GLUT1 in DAC and IDC-P patients. METHODS: The study was conducted on 87 DAC or/and IDC-P patients without any treatment and 97 PAC patients with a Gleason score ≥8 of prostate biopsies and prostatectomy samples between August 2017 and August 2022. We performed immunohistochemical staining and scoring of various cancer component samples from the patients to reflect the protein expression levels of PSMA and GLUT1. RESULTS: PSMA expression in PAC was significantly higher than in DAC/IDC-P (141.2 vs 78.6, p < 0.001). There was no significant difference in PSMA expression between DAC/IDC-P and adjacent PAC (78.6 vs 93.4, p = 0.166). GLUT1 expression was higher in DAC/IDC-P than in adjacent PAC (68.6 vs 51.3, p = 0.007), but was still lower than that in pure PAC (68.6 vs 93.1, p = 0.0014). It is worth noting that GLUT1 membrane expression in DAC/IDC-P was significantly increased than in pure PAC (13.0 vs 6.6, p = 0.025), and in PAC adjacent to DAC/IDC-P (13.0 vs 2.0, p < 0.001). CONCLUSIONS: In DAC/IDC-P tissues, PSMA expression is low, while GLUT1 expression, especially GLUT1 membrane expression is high. These findings imply that DAC/IDC-P may have higher glucose metabolic and raise interest in targeting membrane GLUT1 as a novel anticancer strategy for DAC/IDC-P and other prostate cancer with high glucose metabolism.
引用
- Wang X, Zhou L, Qi L, et al. High GLUT1 membrane expression and low PSMA membrane expression in Ductal Adenocarcinoma and Intraductal Carcinoma of the prostate. Prostate Cancer Prostatic Dis. 2023. PMID: 38007533. doi:10.1038/s41391-023-00759-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。